(Q45658252)

14 December 2017

Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis (English)

1 reference

14 December 2017

0 references

0 references

Paul S McNamara

1

0 references

author name string

Brian F Flanagan

2

1 reference

14 December 2017

Lisa M Baldwin

3

1 reference

14 December 2017

Paul Newland

4

1 reference

14 December 2017

C Anthony Hart

5

1 reference

14 December 2017

Rosalind L Smyth

6

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

14 December 2017

1 reference

14 December 2017

363

1 reference

14 December 2017

1031-1037

1 reference

14 December 2017

9414

1 reference

The pathogenesis of respiratory syncytial virus disease in childhood

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Immune-mediated disease pathogenesis in respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Interleukin 9: a candidate gene for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Interleukin-9 upregulates mucus expression in the airways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Role of IL-9 in the pathophysiology of allergic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Leucocyte populations in respiratory syncytial virus-induced bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Interleukin-9 receptor expression in asthmatic airways In vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Characteristics of the Inflammatory response in bronchial lavage fluids from patients with status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Alveolar macrophage immaturity in infants and young children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

Lung mucus: a clinician's view

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915838-8

7 January 2021

10.1016/S0140-6736(04)15838-8

Identifiers

DOI

1 reference

14 December 2017

1 reference